New technology being introduced at NYU Langone Medical Center could help researchers advance blood biomarker capabilities that show changes in low concentrations of specific proteins present following a neurological injury.
In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.
Sewage sludge, green waste, production residue from the food industry, straw or animal excrement -- with the 'biobattery's' modular concept a much larger range of biomass can be utilized for energy recovery than previously. Researchers show that they can convert organic residues into electricity, heat, purified gas, engine oil and high quality biochar using this process.
Company networks are inflexible -- they are made up of many components that require a good deal of effort to be connected together. That's why networks of the future will be controlled by a central unit. However, this makes them a target for hackers. At CeBIT, Fraunhofer researchers will demonstrate how to protect these future networks.
To guarantee a high quality of their beer, breweries monitor the production process very closely. With a new polymer powder, this monitoring will be able to be faster and simpler in the future. Manufacturers can also test drinks such as milk, juice, cola and red wine with the quick check.
To make ships more eco-efficient, engineers have been working with alternative fuels. A Norwegian engineer is currently pursuing a new approach: With VindskipTM, he has designed a cargo ship that is powered by wind and gas. Software developed by Fraunhofer researchers will ensure an optimum use of the available wind energy at any time.
Iñigo de la Parra Laita, an industrial engineer of the NUP/UPNA-Public University of Navarre, has developed a model that has been patented and which is capable of simulating fluctuations in photovoltaic power. As he explains, 'just by knowing the irradiance recorded in one spot, the number of grouped power stations and the average surface area they occupy, we can simulate what fluctuations may take place in photovoltaic power.'
University of Guam researchers catch 25 times as many rhino beetles as standard pheromone traps with a newly developed cost-effective trap called Tekken.
Scientists at the Critical Materials Institute, headquartered at the Ames Laboratory, have developed a two-step recovery process that makes recycling rare-earth metals easier and more cost-effective. The process uses differences between the solubility properties of difference elements to separate out rare-earth metals.
A novel phase 1 clinical trial that leverages T-cell immunotherapy is now under way at Karmanos Cancer Institute in Detroit and Memorial Sloan-Kettering Cancer Center in New York City, bringing new hope to children and young adults with osteosarcoma and neuroblastoma. This new clinical trial is being funded by charity partners Solving Kids' Cancer and Fishin' For The Cure.